Form D · Biotechnology
Vista Biomedical, Inc.
Las Vegas, NV · CIK 0002005998
Offering snapshot reported Jan 24, 2024 · SEC filing
- Reported sold
- Yet to sell Offering amount: $500K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 24, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-503242
$500,000 at $0.50/share
Source: Form D, filed Jan 24, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Jackson | Director, Executive |
| Philip Messina | Director, Executive |
| Joe Weber | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5217 Rim View Lane
Las Vegas, NV, 89130
Las Vegas, NV, 89130